Cargando…
Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients
BACKGROUND: Mammalian cells contain three functional RAS proto-oncogenes, known as H-RAS, K-RAS, and N-RAS, which encode small GTP-binding proteins in terms of p21(ras)s. RAS genes have been elucidated as major participants in the development and progression of cancer. A single nucleotide polymorphi...
Autores principales: | Mir, Rashid, Ah, Imtiyaz, Javid, Jamsheed, Zuberi, Mariyam, Guru, Sameer, Mirza, Masroor, Farooq, Shazia, Yadav, Prasant, Ray, Prakash C., Gupta, Naresh, Saxena, Alpana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649720/ https://www.ncbi.nlm.nih.gov/pubmed/29147425 http://dx.doi.org/10.14740/wjon912e |
Ejemplares similares
-
Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients
por: Mir, Rashid, et al.
Publicado: (2016) -
miR-486-5p: A Prognostic Biomarker
for Chronic Myeloid Leukemia
por: Ninawe, Anupama, et al.
Publicado: (2021) -
Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
por: Guru, Sameer Ahmad, et al.
Publicado: (2022) -
Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
por: Guru, Sameer Ahmad, et al.
Publicado: (2022) -
microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients
por: Beg Mirza, Masroor Ali, et al.
Publicado: (2019)